Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Antoine Cheret
Raltegravir Pharmacokinetics in Patients on Asunaprevir-Daclatasvir: TABLE 1
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Related publications
Identification of Genotype 2 HCV in Serotype-1 Hepatitis C Patients Unresponsive to Daclatasvir Plus Asunaprevir Treatment
Tohoku Journal of Experimental Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Changes in Serum LDL, PCSK9 and microRNA‑122 in Patients With Chronic HCV Infection Receiving Daclatasvir/Asunaprevir
Biomedical Reports
Genetics
Pharmacology
Molecular Biology
Biochemistry
Neuroscience
Medicine
Toxicology
Pharmaceutics
Retrospective Study of Risk Factors Associated With Hepatic Dysfunction Induced by Daclatasvir/Asunaprevir
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)
Raltegravir for HIV-1 Infected Children and Adolescents: Efficacy, Safety, and Pharmacokinetics
Adolescent Health, Medicine and Therapeutics
Effect of Ginkgo Biloba on the Pharmacokinetics of Raltegravir in Healthy Volunteers
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
The Effect of Hepatic Impairment on the Pharmacokinetics of Asunaprevir, an HCV NS3 Protease Inhibitor
Antiviral Therapy
Infectious Diseases
Pharmacology
Effect of HIV-infection and Menopause Status on Raltegravir Pharmacokinetics in the Blood and Genital Tract
Antiviral Therapy
Infectious Diseases
Pharmacology
Daclatasvir/Asunaprevir Based Direct-Acting Antiviral Therapy Ameliorate Hepatitis C Virus-Associated Cryoglobulinemic Membranoproliferative Glomerulonephritis: A Case Report
BMC Nephrology
Nephrology
Plasma and Intracellular (Peripheral Blood Mononuclear Cells) Pharmacokinetics of Once-Daily Raltegravir (800 Milligrams) in HIV-Infected Patients
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
